KRAS and cancer: Since mitochondria are the primary source of ROS in cancer cells (Gorrini et al, 2013), mitochondria-targeted antioxidants were tested in mouse models of BRAF-driven melanoma and KRAS-driven lung cancer (Le Gal et al, 2021).